IL5 and asthma: Type 2 CRSwNP patients are characterized by the presence of staphylococcal enterotoxin immunoglobulin E (SE-IgE) and type 2 cytokines such as IL-4, IL-5 and IL-13, as well as high asthma comorbidity and recurrence (3–5).